Boule Diagnostics – Presentation of the year-end report 2020
Boule´s proprietary technology at the core of the new platform. Intangible assets are written down by SEK 40 million.
Boule Diagnostics AB (publ) Interim report January–September 2020
Boule Diagnostics – Presentation of the interim report Q3 2020
Boule Diagnostics – Nomination Committee for the 2021 Annual General Meeting
Boule has signed a long-term supply agreement with one of the company’s major OEM clients
Boule strengthens innovation and product development and appoints Helena Börjesson as CTO
Boule Diagnostics AB (publ) Interim report January–June 2020
Boule Diagnostics publishes the interim report Q2 2020 on July 17, 2020 at 08.00 CET
Boule Diagnostics AB writes-off the asset shares in Associate
Cision will store the added information in order to continuously be able to send you the information you’ve chosen to subscribe to. Read more about how Cision process personal data.
Search on the page
Choose your market